Concepedia

F.-X. Mahon

FM

14

Publications

545

Citations

13

H-Index

1995

Active since

Affiliations

Inserm(Current)

Centre Hospitalier Universitaire de Bordeaux

Institut Bergonié

Université de Bordeaux

Hôpital Cardiologique du Haut-Lévêque

F.-X. Mahon is an author at Inserm specializing in oncology, medicine, and hematology.

Top concepts

Publications per year

1995–2022

14

Publications

14

Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase

Francis J. Giles, Hagop M. Kantarjian, Philipp D. le Coutre et al. · Leukemia · 2011 · 95 citations

, , +10

Follow-Up of Complete Cytogenetic Remission in Patients With Chronic Myeloid Leukemia After Cessation of Interferon Alfa

F.-X. Mahon, X. Delbrel, Pascale Cony‐Makhoul et al. · Journal of Clinical Oncology · 2002 · 72 citations

Response at Three Months Is a Good Predictive Factor for Newly Diagnosed Chronic Myeloid Leukemia Patients Treated by Recombinant Interferon-

F.-X. Mahon, C. Fabères, Sophie Pueyo et al. · Blood · 1998 · 57 citations

Response at Three Months Is a Good Predictive Factor for Newly Diagnosed Chronic Myeloid Leukemia Patients Treated by Recombinant Interferon-

F.-X. Mahon, C. Fabères, Sophie Pueyo et al. · Blood · 1998 · 54 citations

Prognosis and prognostic factors for patients with chronic myeloid leukemia: Nontransplant therapy

Joerg Hasford, Markus Pfirrmann, Rüdiger Hehlmann et al. · Seminars in Hematology · 2003 · 47 citations

, , +9

Rows per page

1–5 of 14